Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOTUM | Q6P988 | 8/20 | 0.62 |
| ▸ | POLB | P06746 | 1/20 | 0.60 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.60 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.60 |
| ▸ | FFAR4 | Q5NUL3 | 5/20 | 0.54 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.51 |
| ▸ | SERPINE1 | P05121 | 3/20 | 0.50 |
| ▸ | IDH2 | P48735 | 1/20 | 0.48 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6499990 | 0.91 | FFAR4 (0.58) | NOTUMPOLBCYP2C9CYP2C19FFAR4 | |
| SCHEMBL30173256 | 0.85 | NOTUM (0.85) | NOTUMPOLBSERPINE1IDH2 | |
| SCHEMBL4334462 | 0.85 | NOTUM (0.85) | NOTUMPOLBSERPINE1IDH2 | |
| SCHEMBL2071701 | 0.84 | NOTUM (0.83) | NOTUMPOLBCYP2C9CYP2C19FFAR4 | |
| SCHEMBL2935259 | 0.83 | NOTUM (0.68) | NOTUMPOLBCYP2C9CYP2C19 | |
| SCHEMBL6528497 | 0.79 | LGMN (0.56) | POLBFFAR4PDK2 | |
| SCHEMBL1534319 | 0.78 | RHOC (0.60) | POLBCYP2C9CYP2C19 | |
| SCHEMBL5801907 | 0.78 | NOTUM (0.57) | NOTUMCYP2C19FFAR4PDK2 | |
| SCHEMBL25170450 | 0.77 | NOTUM (1.00) | NOTUMPOLBSERPINE1 | |
| SCHEMBL29957216 | 0.77 | NOTUM (1.00) | NOTUMPOLBSERPINE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2005019200-A2 | ARYL PIPERIDINE DERIVATIVES AS VLA-1 INTEGRIN ANTAGONISTS AND USES THEREOF | ICOS CORPORATION (US) | 2005-03-03 | — | — | WO | disclosed |